1. Richardson GS, Scully RE, Nikrui N and Nelson JH: Com mon epithelial cancer of the ovary (second of two parts). N Engl J Med 1985 (312): 474–483
2. Evans BD, Raju KS, Calvert AH, Harland SJ and Wiltshaw E: Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. Cancer Treat Rep 1983 (67): 997–1000
3. Creaven PJ, Madajevicz S, Pendyala L, Mittelman A, Pontes E, Spaulding M, Arbuck S and Solomon J: Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum (IV) (CHIP). Cancer Treat Rep 1983 (67): 795–800
4. Johnson BL, Fisher Rl, Bender RA, DeVita VT, Chabner BA and Young RC: Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma. Cancer 1978 (42): 2157–2161
5. Bonomi PD, Mladineo J, Morrin B, Wilbanks G and Slayton RE: Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents. Cancer Treat Rep 1979 (63): 137–138